depression Clinical Trials and Research
Also known as: major depressive disorder, clinical depression, mdd, unipolar depression, melancholia, persistent depressive disorder · ICD-10: F32-F33
Depression is a common mood disorder characterized by persistent sadness, loss of interest, and other symptoms that affect daily life. Clinical trial research aims to discover new treatments, understand its causes, and improve existing therapies for better patient outcomes. Find a Trial helps patients search for active studies in this area.
Common questions about depression clinical trials
What are clinical trials for depression?
Clinical trials for depression are research studies that evaluate new ways to prevent, detect, or treat the condition. They test various interventions, such as medications, psychotherapies, or devices, to determine their safety and effectiveness. Data from ClinicalTrials.gov informs these studies.
Who can participate in depression clinical trials?
Eligibility for depression clinical trials varies significantly by study. Factors like age, specific type and severity of depression, overall health, and current medications are considered. Each trial has strict criteria to ensure participant safety and the relevance of the study's findings, as detailed on ClinicalTrials.gov.
What are the different phases of depression clinical trials?
Clinical trials typically progress through phases. Phase 1 focuses on safety, Phase 2 assesses effectiveness and side effects, and Phase 3 compares new treatments to existing ones. Phase 4 studies occur after a treatment is approved, monitoring long-term effects, according to ClinicalTrials.gov.
Do clinical trials for depression cost money?
Generally, study-related medical care, interventions, and tests in clinical trials are provided at no cost to participants. However, other expenses like travel, parking, or lost wages are typically not covered. Specific details are outlined in each trial's consent form, as found on ClinicalTrials.gov.
What types of treatments are being studied for depression?
Researchers are investigating a wide range of treatments, including novel medications, various psychotherapy approaches, brain stimulation techniques (like TMS or ECT), and digital health interventions. These efforts aim to find more effective and personalized options, as seen on ClinicalTrials.gov and NIH RePORTER.
Are there specific biomarkers being studied in depression trials?
Yes, researchers are actively exploring potential biomarkers for depression. These include genetic markers, neuroimaging findings (like fMRI patterns), and blood-based indicators to better understand the condition, predict treatment response, and personalize care. This research is often supported by NIH RePORTER.
What are common exclusion criteria for depression trials?
Common exclusion criteria for depression trials might include certain co-occurring medical conditions, active substance use disorders, a history of specific psychiatric conditions (e.g., bipolar disorder), or current use of medications that could interfere with the study's intervention. These are detailed on ClinicalTrials.gov.
How do researchers decide which depression treatments to study?
Researchers decide based on promising preclinical data, insights into the biological mechanisms of depression, and identified unmet patient needs. The goal is to develop more effective, safer, and personalized therapies, often informed by findings from NIH RePORTER and ClinicalTrials.gov.
How to find a depression trial that fits you
- Describe your depression situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all depression trials →